What You Should Know:
– Ellipsis Health and Ceras Health today announced a partnership that will integrate Ellipsis Health’s breakthrough technology that uses the human voice as a biomarker for mental health and wellbeing into Ceras’ clinical monitoring platform.
– This integration will combine Ellipsis Health’s AI and deep learning technology with Ceras Health’s clinical monitoring and health data analytics platform, enabling real-time severity scores for anxiety and depression to improve care and triage patients in need.
Using the Human Voice as a Biomarker for Mental Health and Well-being
Currently, mental health conditions are at epidemic proportions. In the US, 28 percent of people have depression, while 36 percent suffer from anxiety, and 41 percent reported mental health disorders within the last year, two times more than in 2019. The National Alliance on Mental Health estimates that 55 percent of people with mental illness are not receiving treatment, and there is a projected shortage of up to 30,000 psychiatrists in the US by 2024. This explosive growth, coupled with the difficulty in accessing the right treatment for many populations, is part of the impetus for the Ellipsis Health and Ceras Health partnership. Together, the companies plan to bring greater access to mental health treatment for the more than 18 million Medicare patients who have mental health conditions.
Bringing technology-powered innovation to mental healthcare, Ellipsis Health is giving voice to a new standard of care, pioneering the only clinically validated vital sign for mental health. By harnessing the unique power of the human voice as a biomarker for mental wellbeing, along with machine learning and AI, Ellipsis Health identifies, measures, and monitors the severity of stress, anxiety, and depression at scale. Its technology analyzes a short voice sample to create an objective and scalable clinical decision support tool.
“This unique partnership with Ellipsis Health aligns with Ceras Health’s commitment to providing impactful care for our patients with chronic diseases and innovating how we deliver this care,” said Udaya Devineni, Chief Executive Officer (CEO) of Ceras. “The ability to access mental healthcare has never been more important given these unprecedented times, especially for those patients who are also managing chronic diseases, and we are excited about the potential of providing patients with easy and direct access to mental health support.”
Ceras Health will be using Ellipsis Health’s technology in its digital transitions of care solutions which are transforming how healthcare is delivered, especially for Medicare and other vulnerable populations. By using a combination of 24/7 clinical expertise, remote patient monitoring, artificial intelligence (AI), and advanced data analytics, Ceras Health’s solutions blend clinical expertise and digital tools to help patients get the whole person personalized care they need to drive improvements in their health outcomes.
